Showing results (81-90 of 715) with videos related to
Sort By:
Pageof 72
Expert Opinion on Pharmacotherapy|April 24, 2012
Tyrosine kinase inhibitors in acute and chronic leukemiasMaro Ohanian, Jorge Cortes, Hagop Kantarjian, et al.Cancer Control : Journal of the Moffitt Cancer Center|July 1, 2025
Racial/Ethnic and Age-Related Disparities in Early-Onset Colorectal Cancer Diagnoses and SurvivalMeng-Han Tsai, Jorge Cortes, Kenneth J VegaCancer|October 21, 2010
Monitoring molecular response in chronic myeloid leukemiaJorge Cortes, Alfonso Quintás-Cardama, Hagop M KantarjianCancer|October 6, 2010
Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: Definitions and clinical implicationsJavier Pinilla-Ibarz, Jorge Cortes, Michael J MauroExpert Opinion on Emerging Drugs|March 23, 2011
Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemiaHillary Prescott, Hagop Kantarjian, Jorge Cortes, et al.Expert Review of Hematology|June 15, 2011
Dasatinib for the treatment of chronic myeloid leukemiaAmber Fullmer, Hagop Kantarjian, Jorge Cortes, et al.Cancer Journal (Sudbury, Mass.)|November 23, 2007
Current perspectives on the treatment of patients with chronic myeloid leukemia: an individualized approach to treatmentElias Jabbour, Jorge Cortes, Francis Giles, et al.Expert Review of Hematology|February 25, 2016
Acute myeloid leukemia: advancing clinical trials and promising therapeuticsNaval Daver, Jorge Cortes, Hagop Kantarjian, et al.Leukemia & Lymphoma|November 6, 2012
Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009Yiming Chen, Haijun Wang, Hagop Kantarjian, et al.Cancer Control : Journal of the Moffitt Cancer Center|April 16, 2026
Geographic and Demographic Disparities in Receipt of Treatment for Early-Onset Colorectal CancerMeng-Han Tsai, Steven S Coughlin, Jorge CortesPageof 72